Ofatumumab for Rituximab-Resistant Nephrotic Syndrome

2014116 citationsletterbronze Open Access

Authors

Biswanath Basu · Nil Ratan Sircar Medical College and Hospital

Abstract

Cases of the steroid-resistant nephrotic syndrome that are resistant to rituximab can be difficult to treat. In this report, ofatumumab, an anti-CD20 monoclonal antibody, showed some benefit in five young patients.

Topics & Keywords

Renal Diseases and Glomerulopathies Chronic Lymphocytic Leukemia Research Autoimmune Bullous Skin Diseases

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 370, Issue 13, pp. 1268-1270

DOI: 10.1056/nejmc1308488

Field-Weighted Citation Impact: 6.68